Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Sales, net	$ 8,152	$ 7,862	$ 24,027	$ 28,979
Cost of sales	6,915	6,518	20,086	22,390
Gross profit	1,237	1,344	3,941	6,589
Selling and administrative expenses	1,072	1,772	3,377	5,887
Operating income (loss)	165	(428)	564	702
Other income (expense), net
Change in fair value of derivative liabilities	(174)		(602)	14
Impairment charge on investment in iBio, Inc.	(139)	0	(139)	0
Forbearance fee				(1,000)
Other income (expense), net	(131)	(5)	244	2
Interest expense	(248)	(286)	(736)	(833)
Other expense, net	(692)	(291)	(1,233)	(1,817)
Loss before income taxes	(527)	(719)	(669)	(1,115)
Income tax expense, net	5	19	18	44
Net loss	$ (532)	$ (738)	$ (687)	$ (1,159)
Basic and diluted net loss per common share (in Dollars per share)	$ (0.03)	$ (0.04)	$ (0.03)	$ (0.06)
Weighted average common shares outstanding - basic and diluted (in Shares)	21,080,174	21,036,503	21,080,174	21,012,710